Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CNTF. Out at $13.93 (from $13.44 yesterday). Probably will go higher but yesterday's action made me too nervous <g>
CNTF Guess my buy at $13.44 was a signal for the dumping to begin. Wow.
CNTF. Long at $13.44
NVLS. Added to long at $26.62
Good questions for sure. Thanks for sharing your views. If you have any specific stocks you like, long or short, please feel free to share. As 2Mars said, no-one will bite, and we all profit by informed stock ideas and opinions. Hope you choose to hang around. There's a lot of good people on this board.
Russ
If you can make your year with only a couple of good trades, I think we would all like to know what they are. I know my life would be a lot easier. I think everyone would appreciate your views on the macro trend and any long term trades you consider worthwhile.
NVLS Long at $27.96
That would be nice. thanks.
Russ
LIFC. showing a little energy finally this morning. Any thoughts on where it might go? thanks.
Russ
ADBL. Zeev. Gave up in frustration and sold as it dropped through the 9.90's again for essentially break even. Good luck with it if you hold.
Russ
LIFC. Falling like a rock the last 2 days. Any opinions on a 'safe' place to jump in.
Russ
LIFC I was thinking of following you long on this stock, but it seemed to fall off the pier. Guess I'll wait a bit.
Russ
I think you were correct earlier. This stock needs time for the former holders to bail. Several weeks ago I owned CNXT at $1.85 when Cramer mentioned it. It rose a little as VTSS is doing, then stalled for a while. He mentioned it every few days it seemed and eventually I sold for over $3. Maybe the same thing will happen here. Certainly worth keeping on the streamer.
Russ
Thanks. good advice. I'm keeping it on the streamer.
Russ
ADBL. Looks like it might want to test our resolve again at $9.85.
Russ
VTSS. Thanks for the post. I did see that before I bought, but I figured it might be a good play for a few hundred shares, since $3.75 was over 40 cents away. But it didn't look good so I backed out with just an 8 cent loss. Now it will probably take off. LOL.
Russ
VTSS. Thanks for the heads up. Nibbled VTSS @ $3.33. We'll see if the Cramer effect makes it run some more.
*** Edit. Jumped back out at $3.25. So much for the Cramer effect.
Russ
ADBL. Zeev, it seems to have held well in the $9.90's on the highest volume day in a couple of weeks. Hopefully it portends well for a nice pop. Holding for now.
Russ
ADBL. You're right. Kind of surprised, but it really dropped after my last post. maybe I better keep quiet for a while. LOL
I agree. But I'm going to hold for a little while and hope it's just a delayed reaction (UP) <G> Not headed in the right direction so far though.
Russ
Joined you long in ADBL at 9.96
Russ
YHOO. Long at $33.37. This stock's got to find a bottom soon.
Russ
Zeev, Any interest in INTC at this level? Thanks.
Russ
SNDK. Out at $66.20
SNDK. Long at $64.31
Thanks for the reminder. Just called that number to block cell phone spam. Also tried calling your daughter's number, but the recording said not to use a cordless phone. That's all I have in the house. Sorry I couldn't help out.
Tantal. I think that's good advice. I was hoping for a bounce, but I've been feeling uncomfortable ever since I bought it even though the position was small. I'm out now with just a small lunch money loss. Will watch and wait. Thanks for the advice.
Russ
GE. Bought a little to tuck away @ $32.92
GE. Normally don't follow it, but keeping it on the watch list for now
GE. Looks interesting. Bear, where would you go long this stock? Or would you? Thanks.
SIRI. In at $5.98
TASR
*DJ Taser Says District Court Dismisses Training Injury Suit
*DJ Piper Jaffray Cuts LifeCell To Mkt Perform From Outperf
ASTM
Aastrom Biosciences Receives NIH Grant Extending Proprietary Adult Stem Cell Process to Other Tissues
PR Newswire - August 16, 2005 05:45
-- Phase II Grant to Support Bone Formation and Vascularization Capabilities of Company's Tissue Repair Cells --
ANN ARBOR, Mich., Aug 16, 2005 /PRNewswire-FirstCall via COMTEX/ -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) today announced that it has received a Small Business Innovation Research Phase II grant from the National Institutes of Health (NIH) entitled "Clinical-Scale Production of Osteoprogenitor Cells." The two- year Phase II grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) totals $740,000, of which $324,000 has been received for the first year of this study. This Phase II grant award follows a Phase I grant issued to Aastrom in 2003 by the NIH's National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Aastrom's Tissue Repair Cells (TRCs), a bone marrow-derived adult stem and progenitor cell mixture, have been shown to form bone and small blood vessel tubes in laboratory tests. This new grant will support investigations to further increase the overall numbers of the targeted cells thought to be especially important for bone regeneration. This includes studies of the cells contained in TRCs, to better understand how accessory cells support the growth of stem and progenitor cells so they are optimized when the surgeon is ready to use them for bone or vessel regeneration. Another significant goal of this study is the evaluation of Aastrom's unique cell production process in the AastromReplicell(R) System to facilitate the transition to commercial- level cell manufacturing.
"Considering the highly competitive nature of NIH awards, we are very excited to receive funding to continue our work using TRCs for tissue regeneration in multiple medical indications," said Janet M. Hock, B.D.S., Ph.D., Chief Science Officer and Vice President Global Research of Aastrom. "Further understanding how TRCs contribute to the regeneration of blood vessels should allow us to better utilize our cell products for bone regeneration in orthopedic applications, and for other conditions where regulated revascularization is needed."
The studies supported by this grant will be completed at Aastrom under the direction of Kristin Goltry, Ph.D., in collaboration with Case Western Reserve University, under the direction of James Dennis, Ph.D., and with the University of Michigan, under the direction of James Goulet, M.D. Dr. Goulet is a principal investigator in Aastrom's Phase I/II multi-center human clinical trial for the treatment of severe bone fractures, currently being conducted at 5 sites in the United States, including the University of Michigan Health Center in Ann Arbor. The other participating centers are: Lutheran General Hospital, Park Ridge, IL, William Beaumont Hospital, Royal Oak, MI, Lutheran Medical Center, Brooklyn, NY, and the University of Nebraska Medical Center, Omaha, NE.
Ameritrade. Anyone else having trouble logging in? Can't get on the site.
Russ
SIRI. Out essentially flat (+.02) from Buy this morning. Will watch from here.
Russ
"Watch SIRI at 7.02+...it should explode up from there"
That would certainly make me happy <GGG>
Russ
OT
Lee. I just double checked the IMDB web site. Gabe Dell was one of the original Dead End Kids in the movie Dead End made in 1937. They do list that Harry Kellerman movie in his credits (1971).
Russ
Hi Joe. I basically agree with everything you said. I just think there might be a bounce here into the quarterly report. I sure won't hang around long in any case, and never hold any stocks through their reports. I've been burned too many times doing that.
Russ
OTOT
Hi Nomoweed. I believe his last name was Dell. But I do recall him being on the show now that you mention it. I still occassionaly watch old movies with those guys. First known as the Dead End Kids, then the Bowery Boys, and then, I think, The East Side Kids. Huntz Hall and Leo Gorcey were great.
Russ